2014
A risk score model predictive of the presence of additional disease in the axilla in early-breast cancer patients with one or two metastatic sentinel lymph nodes Canavese G, Bruzzi P, Catturich A, et al (IRCCS-AOU San Martino – IST, Genova, Italy) Eur J Surg Oncol 40:835-842, 2014§
Chagpar A. A risk score model predictive of the presence of additional disease in the axilla in early-breast cancer patients with one or two metastatic sentinel lymph nodes Canavese G, Bruzzi P, Catturich A, et al (IRCCS-AOU San Martino – IST, Genova, Italy) Eur J Surg Oncol 40:835-842, 2014§. Breast Diseases A Year Book Quarterly 2014, 25: 332-333. DOI: 10.1016/j.breastdis.2014.10.007.Peer-Reviewed Original Research
2011
P3-07-26: How Generalizable Is the Patient Population Enrolled in ACOSOG Z11?
Lannin D, Killelea B, Grube B, Horowitz N, Chagpar A. P3-07-26: How Generalizable Is the Patient Population Enrolled in ACOSOG Z11? Cancer Research 2011, 71: p3-07-26-p3-07-26. DOI: 10.1158/0008-5472.sabcs11-p3-07-26.Peer-Reviewed Original ResearchPositive sentinel nodesSentinel node biopsySentinel nodesPositive nodesAxillary dissectionNode biopsyLower axillary recurrence ratePositive sentinel lymph nodesAxillary recurrence rateNode-positive patientsNeo-adjuvant chemotherapyPercentage of patientsNegative sentinel nodesBreast cancer patientsSentinel lymph nodesEligibility requirementsLumpectomy patientsZ11 trialT4 tumorsPositive patientsLymph nodesRecurrence ratePatient populationCancer patientsInstitutional databaseFactors affecting lymphovascular invasion in node-positive breast cancer patients.
Cornwell L, McMasters K, Chagpar A. Factors affecting lymphovascular invasion in node-positive breast cancer patients. Journal Of Clinical Oncology 2011, 29: 24-24. DOI: 10.1200/jco.2011.29.27_suppl.24.Peer-Reviewed Original ResearchBreast cancer patientsLVI positivityCancer patientsExtracapsular extensionLarge tumorsNode-positive breast cancer patientsPositive lymph nodesProportion of patientsCohort of patientsPoor prognostic factorProspective multicenter studySynoptic pathology reportsBreast cancer tumorsBreast practicePositive nodesLarge metastasesLymphovascular invasionPatient agePrognostic factorsSurgery typeClinicopathologic factorsLymph nodesMulticenter studyVascular invasionPathology reports
2009
Use of intraoperative breast cancer sentinel lymph node (SLN) assay to predict of ≥4 positive (+) lymph nodes (LN)
Chagpar A, Blumencranz P, Whitworth P, Deck K, Rosenberg A, Simmons R, Reintgen D, Beitsch P, Saha S, Julian T. Use of intraoperative breast cancer sentinel lymph node (SLN) assay to predict of ≥4 positive (+) lymph nodes (LN). Journal Of Clinical Oncology 2009, 27: 530-530. DOI: 10.1200/jco.2009.27.15_suppl.530.Peer-Reviewed Original ResearchSentinel lymph nodesLymph nodesFinal pathologyTumor sizeMedian cycle timeBreast cancer sentinel lymph nodesTotal lymph nodesMedian tumor sizePositive lymph nodesImmediate breast reconstructionHematoxylin-eosin stainingReceiver operator curveCohort of interestBLN AssayQuantitative RT-PCRSLN metastasisProspective studyBreast reconstructionReal-time RT-PCR analysisMedian numberClinical utilityRadiation therapyPatientsMultivariate analysisMammaglobin
2008
QS127. Response of Axillary Lymph Nodes to Neoadjuvant Chemotherapy Parallels Primary Tumor Response in Breast Cancer Patients
Pilavas J, Napper L, Clements K, Chagpar A. QS127. Response of Axillary Lymph Nodes to Neoadjuvant Chemotherapy Parallels Primary Tumor Response in Breast Cancer Patients. Journal Of Surgical Research 2008, 144: 318. DOI: 10.1016/j.jss.2007.12.367.Peer-Reviewed Original Research